Glaxo Hit with $2.5M Paxil Verdict in Philly

A Philadelphia jury has awarded $2.5 million to the family of a man who was born with birth defects after his mother took Paxil, an antidepressant manufactured by GlaxoSmithKline.

The case was considered a test of the viability of more than 600 cases claiming Glaxo hid knowledge of birth defect risks tied to the drug, which generated $942 million in profits for Glaxo last year.

Sean Tracey of The Tracey Law Firm represented Lyam Kilker and his mother, Michelle David. He told The American Lawyer that jurors felt Glaxo never adequately studied their drug, particularly after animal testing detected problems.

Glaxo was defended by litigation star Chilton Varner of King & Spalding (a regular of the Lawdragon 500) and Joseph O’Neil of Lavin O’Neill in Philadelphia


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s